Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.
10.3389/fpubh.2020.552028 · 2021 · External reference
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.
10.1016/s2214-109x(22)00501-0 · 2023 · External reference
Unresolved reference
External reference
Opportunities and challenges for human papillomavirus vaccination in cancer.
10.1038/nrc.2018.13 · 2018 · External reference
Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.
10.1155/2014/157895 · 2014 · External reference
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21).
10.1073/pnas.1014074107 · 2010 · External reference
Comprehensive Control of Human Papillomavirus Infections and Related Diseases.
10.1016/j.vaccine.2013.10.001 · 2013 · External reference
Unresolved reference
2016 · External reference
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age.
10.1038/bjc.2011.185 · 2011 · External reference
Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
10.1016/j.vaccine.2008.04.074 · 2008 · External reference
Comparison of Ophthalmic Sponges for Measurements of Immune Markers from Cervical Secretions
2004 · External reference
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine.
10.4161/hv.6.12.13399 · 2010 · External reference
Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® sponges
10.1016/j.vaccine.2018.03.034 · 2018 · External reference
Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions.
10.1086/315364 · 2000 · External reference
Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia
10.1002/ijc.2910430109 · 1989 · External reference
Cervical Mucus Antibodies against Human Papillomavirus Type 16, 18, and 33 Capsids in Relation to Presence of Viral DNA [Internet].
10.1128/jcm.34.12.3056-3062.1996 · 1996 · External reference
Comparison of multiplex-serology and ELISA based methods in detecting HPV16 L1 antibody responses in paired saliva and serum samples of healthy men
10.1016/j.jviromet.2019.04.007 · 2019 · External reference
Chaturvedi AK, Hagensee ME. Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals
2003 · External reference
First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions.
10.1016/j.jcv.2019.05.004 · 2019 · External reference
Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine.
10.3389/fimmu.2020.01657 · 2020 · External reference
HPV vaccination: Are we overlooking additional opportunities to control HPV infection and transmission
10.1016/j.ijid.2019.09.006 · 2019 · External reference
Delivering on the promise: HPV vaccines and cervical cancer
10.1038/nrmicro867 · 2004 · External reference
Vaccination of young women decreases human papillomavirus transmission in heterosexual couples: Findings from the HITCH cohort study
10.1158/1055-9965.epi-19-0618 · 2019 · External reference
Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals.
10.2196/11284 · 2019 · External reference
Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: A randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples.
10.1136/bmjopen-2020-039383 · 2020 · External reference
Protection to Self and to One’s Sexual Partner After Human Papillomavirus Vaccination: Preliminary Analysis From the Transmission Reduction And Prevention with HPV Vaccination Study.
10.1097/olq.0000000000001620 · 2022 · External reference
The E4 protein; structure, function and patterns of expression
10.1016/j.virol.2013.07.008 · 2013 · External reference
Unresolved reference
2016 · External reference
Human Papillomavirus Type 31b Infection of Human Keratinocytes Does Not Require Heparan Sulfate
10.1128/jvi.79.11.6838-6847.2005 · 2005 · External reference
Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line.
10.1099/0022-1317-83-11-2753 · 2002 · External reference
Mutations in HPV18 E1ˆE4 impact virus capsid assembly, infectivity competence, and maturation.
10.3390/v9120385 · 2017 · External reference
Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants.
10.1016/j.ebiom.2020.103165 · 2021 · External reference
Electron microscopic detection of human papillomavirus particles in oral proliferative lesions.
1989 · External reference
Electron microscopic detection of papilloma virus particles in selected koilocytotic cells in a routine cervical smear. Acta Cytol
1979 · External reference
Multiplexed Serologic Assay for Nine Anogenital Human Papillomavirus Types.
10.1128/cvi.00348-09 · 2010 · External reference
Unresolved reference
External reference
Unresolved reference
2018 · External reference
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
2018 · External reference
Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination
10.1016/j.vaccine.2019.04.099 · 2019 · External reference
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
10.1016/s0140-6736(19)30298-3 · 2019 · External reference
Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects
10.1093/cid/ciaa1770 · 2021 · External reference
Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review.
10.1080/14760584.2018.1471986 · 2018 · External reference
Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals
10.1016/j.vaccine.2023.07.031 · 2023 · External reference
Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
10.1016/j.ypmed.2020.106166 · 2020 · External reference
